Dr. Julian Lieb wrote a lengthy, technical comment at the end of yesterday’s post. I invited Dr. Lieb to contribute further material about the positive affects of antidepressants against cancer. Here is Dr. Lieb’s response:

I am a semi-retired, former, Yale medical school professor, and author or coauthor of 48 articles and 11 books. In 2001, I published the first of five reviews on the remarkable anticancer properties of antidepressants. Access Medline or Pubmed, and enter “antidepressants” and “cancer,” and you may retrieve about 70 clinical, epidemiological, and laboratory studies confirming the anticancer properties of antidepressants.
Antidepressants can arrest tumors even in advanced stages, occasionally eradicate them, and significantly extend life. It appears that they may be effective for many cancers, including those considered resistant, such as liver, kidney, and lung cancers, gliomas, neuroblastomas, inflammatory breast cancers, resistant lymphomas, and multiple myelomas. Despite the overwhelming weight of evidence contributed by hundreds of laboratories, not one cancer organization, including NCI and ACS, has come forward to support the innovation. It has been said, that when clinical progress occurs, research funds dry up.
In 1990, I evaluated a woman with invasive, inflammatory breast cancer who was given a poor prognosis following standard treatment. I treated her with a succession of antidepressants, and when relocating in 2003, she was in good health. An acquaintance had taken an antidepressant for many years when she developed pancreatic cancer. I suspected that the medication might have lost its effectiveness, until she was declared cancer free after a course of chemotherapy. Another acquaintance had a cancerous kidney removed, and was declared cancer free. Four years later, she was shown to have a large metastatic nodule in a lung. Five years after she started an antidepressant at a low dose, the nodule had shrunk.

Major innovations usually follow decades of stagnation, are often simple, and emerge from unexpected and improbable sources. Clinical research is often light years ahead of basic research, but propagandists wouldn’t have you believe that. A friend has a Béarnaise mountain dog, which last June rapidly lost 30 lbs due a lymphoma. He improved a few days after starting an antidepressant, and is in full remission. In America, a dog can receive cutting edge treatment for cancer, which humans cannot.

Sincerely, Julian Lieb, M.D

Interesting, don’t you think? Add antidepressants to a long list of alternative cancer therapies which are ignored or brushed aside by mainstream medicine.

Feel good and keep smiling! Pat

Leave a Reply